Mitochondrial Dysfunction in Cardiovascular Disease

Mitochondrial dysfunction has wide-ranging effects on cellular function and has been implicated in the pathogenesis of a variety of cardiovascular diseases.

September 21, 2021

Quantification of NADH:ubiquinone oxidoreductase (complex I) content in biological samples.

The Journal of Biological Chemistry
Fariha AnsariAlexander Galkin
September 20, 2021
Open Access

OGT controls mammalian cell viability by regulating the proteasome/mTOR/ mitochondrial axis

BioRxiv : the Preprint Server for Biology
X. LiAnjana Rao
September 20, 2021

A mechanistic insight into the biological activities of urolithins as gut microbial metabolites of ellagitannins.

Phytotherapy Research : PTR
Seyyed Hossein HasheminezhadMilad Iranshahy
September 20, 2021
Open Access

Developmental Angiogenesis Requires the Mitochondrial Phenylalanyl-tRNA Synthetase.

Frontiers in Cardiovascular Medicine
Bowen LiYuanming Wu
September 20, 2021

High uric acid promotes mitophagy through the ROS/CaMKIIδ/Parkin pathway in cardiomyocytes in vitro and in vivo.

American Journal of Translational Research
Kai GaoZhi Li
September 16, 2021
Open Access

Maternal obesity causes fetal cardiac hypertrophy and alters adult offspring myocardial metabolism in mice

BioRxiv : the Preprint Server for Biology
Owen R VaughanT. Jansson
September 16, 2021

Quercetin improves myocardial redox status in rats with type 2 diabetes.

Endocrine Regulations
Nataliia I GorbenkoTetiana S Litvinova
September 16, 2021

miR-210 hypoxamiR in angiogenesis and diabetes.

Antioxidants & Redox Signaling
Germana ZaccagniniFabio Martelli
September 15, 2021

Hydrogen sulfide in liver glucose/lipid metabolism and Non-Alcoholic Fatty Liver Disease.

European Journal of Clinical Investigation
Inês Mateus, Carina Prip-Buus
September 10, 2021
Open Access

Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review.

International Journal of Molecular Sciences
Syeda K ShahzadiYajnavalka Banerjee
September 9, 2021

Chronic Diclofenac Exposure Increases Mitochondrial Oxidative Stress, Inflammatory Mediators, and Cardiac Dysfunction.

Cardiovascular Drugs and Therapy
Phung N ThaiPadmini Sirish
September 7, 2021

Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection.

ESC Heart Failure
Daniel ScheiberRalf Westenfeld
September 7, 2021

A coumarin-based TICT fluorescent probe for real-time fluorescence lifetime imaging of mitochondrial viscosity and systemic inflammation in vivo.

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Yun LiangWeiying Lin
September 7, 2021

Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases.

Current Topics in Medicinal Chemistry
Wen PengYueqing Zheng
September 6, 2021
Open Access

The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease.

Molecular Therapy. Nucleic Acids
Yulin ZouTao Yu
September 6, 2021
Open Access

The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications.

Frontiers in Pharmacology
Emma L SollyJoanne T M Tan

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved